Trial record 1 of 1 for:    INCB 18424-258
Previous Study | Return to List | Next Study

Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis

This study is currently recruiting participants.
Verified February 2014 by Incyte Corporation
Sponsor:
Information provided by (Responsible Party):
Incyte Corporation
ClinicalTrials.gov Identifier:
NCT01348490
First received: May 4, 2011
Last updated: February 7, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: February 2018 (Final data collection date for primary outcome measure)
No publications provided by Incyte Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):